XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
SHAREHOLDERS' EQUITY (Issuance of Shares) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Apr. 14, 2020
shares
Oct. 10, 2018
USD ($)
$ / shares
Jun. 14, 2018
USD ($)
$ / shares
shares
Mar. 16, 2020
$ / shares
shares
May 25, 2018
USD ($)
Jun. 30, 2021
USD ($)
shares
Jun. 30, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
shares
Jun. 30, 2021
₪ / shares
shares
Dec. 31, 2020
₪ / shares
shares
May 25, 2018
₪ / shares
Ordinary shares, par value | ₪ / shares                 ₪ 0.01 ₪ 0.01  
Ordinary shares, shares authorized | shares                 200,000,000 200,000,000  
Warrants purchase to ordinary shares | shares             3,504,061   89,557    
Deferred participation of BMS in R&D expenses           $ 4,121          
Proceeds from warrant exercised           425 $ 16,609        
Warrants purchase to ordinary shares remain outstanding | shares                 297,469    
At The Market Offering Program [Member]                      
Ordinary shares, par value | ₪ / shares                     ₪ 0.01
Proceeds from issuance of common stock         $ 25,000     $ 22,914      
Issuance of shares, net, shares | shares               7,245,268      
Issuance expenses               $ 781      
Agreement [Member] | Registered direct offering [Member]                      
Proceeds from issuance of common stock     $ 19,767                
Issuance expenses     $ 1,233                
Ordinary shares, shares authorized | shares     5,316,457                
Warrants purchase to ordinary shares | shares     4,253,165                
Offering price per share | $ / shares     $ 3.95                
Exercise price of warrants | $ / shares     $ 4.74                
Expiration period of warrants     5 years                
Master Clinical Agreement [Member]                      
Proceeds from issuance of common stock   $ 2,424,243                  
Offering price per share | $ / shares   $ 4.95                  
Equity investment   $ 12,000                  
Percentage of closing price   33.00%                  
Collaborative Arrangements [Member]                      
Proceeds from issuance of common stock           7,788          
Issuance expenses           $ 91          
SVB Leerink LLC and Stifel, Nicolaus & Company [Member]                      
Issuance of shares, net, shares | shares       8,333,334   8,816,339          
Issuance expenses           $ 5,200          
Offering price per share | $ / shares       $ 9.00              
Proceeds from ordinary shares in offering           $ 74,147          
SVB Leerink LLC and Stifel, Nicolaus & Company [Member] | Underwriters [Member]                      
Issuance of shares, net, shares | shares 483,005                    
Offering price per share | $ / shares       $ 8.46